Skip to content

CELGENE

Absorbed by Bristol-Myers Squibb Belgium on 30-09-2022 KBO/BCE: BE 0882.012.387 subsidiary of

Lifetime

16 annual accounts with figures on one time axis
peak of €164.0m in 2021
€164.0m▲ 2.9%
peak of €5.2m in 2020
€4.7m▼ 10.2%
peak of €32.2m in 2021
€32.2m▲ 17.0%
€38.8m▲ 115%
peak of 50.3 FTE in 2016
24 FTE▼ 14.3%
Board4 names since 2017
3 directors and 2 others
Owners2 names in the annual accounts
consolidates
Documentsfilings and deeds
27-06-202234 days before the deadline
2021financial year
Staff from 28 FTE to 24 FTE resigns as director 10-12Registered office moved from Braine-l'Alleud to Watermael-Boi… 15-10 appointed as statutory auditor 19-08Registered office moved to Brussels 15-07Equity from €27.5m to €32.2m

Key points

from the 2021 annual accounts, the last ones filed

Staff

24 FTE from 50.3 in 2016

Between 2016 and 2021, the number of full-time equivalents fell by 52%.

Payment terms

88 days to suppliers
Suppliers
37 to 88
Customers
81 to 87

CELGENE pays its suppliers 51 days later than in 2020. Customers pay 6 days later.

Filings

16 annual accounts since 2006
AprilJune31 JulyOctober201020152020

The 2019 accounts came 21 days late. The other nine of the last ten were filed on time.

Board and ownership

Manager, since 19-09-2017
Director, since 23-03-2020
Director, since 01-09-2021
Auditor,
  • consolidatesannual accounts 2021
Board & ownership

Recent changes

Merger: absorbed by Bristol-Myers Squibb Belgium SA General meeting of 30-09-2022 · Gazette deed
Merger proposal: to be absorbed by Bristol-Myers Squibb Belgium . holds all the shares · Gazette deed
Resignations & appointments holds all the shares · Gazette deed
1 director appointed, 2 resignations and resign · appointed · General meeting of 01-12-2021 · Gazette deed
All 55 events

Official details

Source: KBO
Status
Absorbed by Bristol-Myers Squibb Belgiummerger by absorption, September 2022
Activity
“La recherche et le développement, les tests cliniques, la distribution, la vente, l'achat, l'import…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO
Joint committee
207White-collar workers in the chemical industry · annual accounts 2021
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2021

€71.0m▲ 55.9%
Employeeson 31-12-2021
23
Filing
Filed on 27-06-2022
Financials

Insights on CELGENE

Absorbed by Bristol-Myers Squibb Belgium in September 2022. The last annual accounts are for financial year 2021.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CELGENE

What is the company number of CELGENE?
The company number of CELGENE is 0882.012.387. The VAT number is the same number with BE in front: BE 0882.012.387.
What is the legal form of CELGENE?
The KBO register gives CELGENE the legal form “SRL”.
Is CELGENE still active?
No. Absorbed in a merger on 30-09-2022.Company details
How many employees did CELGENE have?
CELGENE had an average of 24 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
Which joint committee does CELGENE fall under?
In its 2021 annual accounts, CELGENE states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of CELGENE?
The turnover of CELGENE was €164.0m in financial year 2021, according to the filed annual accounts.
Is CELGENE profitable?
In financial year 2021, CELGENE made a profit of €4.7m.
Where can I find the annual accounts of CELGENE?
CELGENE filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2021.

Next steps

Keep this company with today's facts in a case file.